AAVantgarde Bio
ID: 12811619AAV-Gene therapy platform for inherited retinal diseases (IRDs)
2
Funding Rounds
$206.0m
Money raised
Recent Funding Rounds
Overview
AAV-Gene therapy platform for inherited retinal diseases (IRDs)
- Website:
- Headquarters: Milan
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Al***** Au******* |
|
- |
Funding
Funding series
Funding Series Analysis
The company AAVantgarde Bio has raised a total of $206m in funding over 2 rounds.
Key Insights:
- AAVantgarde Bio Series B Round, November 2025: $141m
- AAVantgarde Bio June 2023 Series A Funding Round: $65m
Industries
AAVantgarde Bio is active in the following industries: